Please provide your email address to receive an email when new articles are posted on . Complications from the use of punctum plugs to treat aqueous insufficiency are fairly uncommon; however, adverse ...

Please provide your email address to receive an email when new articles are posted on . Punctal plugs are criticized by some due to their possible connection to granulomas and dacryocystitis. For this ...

BEDFORD, Mass., Aug. 20, 2012 /PRNewswire/ -- Following encouraging results from Ocular Therapeutix's travoprost punctum plug feasibility study, the company is now entering a pilot Phase II clinical ...

A retrospective administrative claims analysis of treatment options for dry eye disease (DED) evaluated treatment patterns and utilization characteristics of patients receiving cyclosporine, punctal ...

Allogeneic haematopoietic SCT is performed for the treatment of many diseases. One of the major success-limiting factors after transplantation is the development of GvHD, which may lead to severe ...

Completion of Facility Enables Initiation of Phase 3 Clinical Trial of Nepafenac in Patients Undergoing Cataract Surgery AUSTIN, Texas, Sept. 12, 2023 /PRNewswire/ -- Mati Therapeutics Inc. ("Mati") ...

VANCOUVER, July 28 /PRNewswire-FirstCall/ - QLT Inc. (NASDAQ: QLTI; TSX: QLT) ("QLT" or the "Company") today announced encouraging interim data from an ongoing Phase ...

The first tear duct implant developed to treat inflammation and pain following cataract surgery has been shown to be a reliable alternative to medicated eye drops, which are the current standard of ...

Up to twenty patients will be enrolled at Singapore National Eye Center and the National University Hospital in Singapore. Patients with documented ocular hypertension or open-angle glaucoma are ...

We investigated the efficacy of lacrimal punctal occlusion surgery with a cautery device in patients with chronic GVHD (cGVHD)-related dry eye, with recanalization of puncta and recurrent punctal plug ...

GLENDORA, CA--(Marketwired - June 17, 2013) - OASIS Medical Inc., manufacturer and distributor of high quality reusable and disposable surgical instruments, punctal occlusion devices, and ocular ...

Two-month sustained release drug may improve therapy over topical drop administration. BEDFORD, Mass., Aug. 20, 2012 -- Following encouraging results from Ocular Therapeutix's travoprost punctum plug ...